GLP-1(7-36)

We are GLP-1(7-36) CAS:119637-73-9 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Chemical Name:GLP-1(7-36)
CAS.NO:119637-73-9
Synonyms:GLP-1(7-36)
glucagon-like peptide I (7-36)amide
Glucagon-like peptide 1 (7-36)amide
GLP-1(7-36), IRP peptide
 
Physical and Chemical Properties:
Molecular Formula C151H229N41O46
Molecular Weight 3354.73
Specification:
Appearance:White to off-white powder
Assay:≥98.0%
 
Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:Potent stimulator of insulin released in perfused mammalian pancreas.

GLP-1(7-36)


Related News: “So far, the finding is still under preliminary study, and a large number of experiments is needed to test if it is effective on patients,” it said, citing the WHO in saying that no proven effective drugs to prevent or treat the Wuhan coronavirus are currently available.118811-07-7 ViiV, in which Pfizer and Shionogi have small stakes, said it received a so-called complete response letter (CRL) from the FDA in which the regulator questioned the treatment’s chemistry, manufacturing and controls process, but not its safety.4-Nitroisoindolin-1-one CAS:366452-97-3 ViiV, in which Pfizer and Shionogi have small stakes, said it received a so-called complete response letter (CRL) from the FDA in which the regulator questioned the treatment’s chemistry, manufacturing and controls process, but not its safety.2-chloro-5-(trifluoromethyl)benzene-1,3-diamine DMF is the main management method for APIs in developed countries in Europe and the United States. Under the DMF system, API companies can submit DMF filing documents to the regulatory authority at any time, but the regulatory authority will not conduct technical reviews on them. When the drug is administered, the regulatory authority will associate and review the drug substance and the preparation.The Company’s first-of-kind approach involves engineering human iPSCs in a one-time genetic modification event and selecting a single engineered iPSC for maintenance as a clonal master iPSC line.

Related Products
Product Name
2-Propyl-1H-imidazole-4,5-dicarboxylic acid View Details
dimethyl 2-(4-methoxycarbonyl-2-nitrophenyl)propanedioate View Details
2,2,2-Trifluoroethyl p-toluenesulfonate Cas:433-06-7 View Details
(E)-4-Ethoxy-1,1-difluorobut-3-en-2-one Cas:285135-89-9 manufacturer 5-methoxy-3,4-dihydro-1H-naphthalen-2-one manufacturer CAS:167078-06-0 Cytec light stabilizer UV-3853PP5 manufacturer 5-Fluoro-2-nitrobenzoic acid manufacturer Chitosan 2-hydroxypropanoate (salt) Cas:66267-50-3 manufacturer